General Principles - The Ground Rules
- Live vaccines: Generally contraindicated due to risk of vaccine-induced disease.
- Killed/Inactivated vaccines: Safe, but may have ↓ immunogenicity. May require higher doses or extra boosters.
- Optimal Timing:
- Administer necessary vaccines preferably ≥4 weeks before initiating immunosuppressive therapy.
- Postpone live vaccines for ≥3 months after chemotherapy; ≥6 months for anti-B cell antibodies (e.g., Rituximab).
- Household Contacts: Should be fully vaccinated (including MMR, Varicella) to provide a protective cocoon.
⭐ After solid organ transplantation, live vaccines are generally withheld. Inactivated vaccines can be given starting 3-6 months post-transplant, once immunosuppression is stable.

Primary Immunodeficiencies - Congenital Gaps
- Core Principle: Vaccination strategy hinges on the specific immune defect. The main danger lies with live attenuated vaccines causing iatrogenic disseminated disease.
- Key Contraindications:
- Severe T-cell defects (e.g., SCID, complete DiGeorge): ALL live vaccines (viral & bacterial) are absolutely contraindicated. Household contacts should also avoid OPV.
- Severe Humoral/B-cell defects (e.g., XLA): Live vaccines contraindicated. Inactivated vaccines are safe but may have poor efficacy; check antibody titres post-vaccination.
- Phagocytic defects (e.g., CGD): Live bacterial vaccines (BCG, oral typhoid) are contraindicated. Live viral vaccines (MMR, Varicella) are generally safe.
⭐ In Severe Combined Immunodeficiency (SCID), rotavirus vaccine can cause severe, persistent gastroenteritis, and BCG can lead to fatal disseminated BCG-osis.
Secondary Immunosuppression - Acquired Weaknesses
-
General Principle: Avoid live vaccines in severely immunocompromised states. Inactivated vaccines are safe but may have ↓ immunogenicity.
-
HIV Infection:
- Strategy depends on CD4 count. Live vaccines (MMR, Varicella) are permitted if CD4 count >200 cells/µL & CD4% >15%.
- BCG is absolutely contraindicated regardless of CD4 status.
- Inactivated vaccines are safe but may have a suboptimal response.
-
Malignancy / Chemotherapy:
- Live vaccines: Contraindicated during and for 3-6 months after chemotherapy. Administer ≥4 weeks before starting.
- Inactivated vaccines: Give ≥2 weeks before or 3 months after chemotherapy for optimal response.
-
Asplenia (Anatomic or Functional):
- High risk for encapsulated bacteria: S. pneumoniae, H. influenzae type b, N. meningitidis.
- Vaccinate ≥2 weeks before elective splenectomy or ≥2 weeks after.
- Mandatory vaccines: Pneumococcal (PCV, PPSV23), Meningococcal (conjugate, MenB), Hib.
⭐ For patients post-chemotherapy, the standard waiting period for administering live vaccines is at least 3 months. This ensures immune reconstitution and vaccine safety.
Household Contacts - Cocooning the Vulnerable
"Cocooning" protects the immunocompromised by vaccinating their close contacts.
- Live vaccines: Generally safe for contacts, with key exceptions.
- Avoid: Oral Polio Vaccine (OPV) due to shedding; use IPV instead.
- Recommended: MMR and Varicella vaccines are encouraged.
- Influenza: All household members should receive the annual injectable flu shot.
⭐ If a varicella-vaccinated contact develops a rash, they must avoid the patient until all lesions have crusted over.
High‑Yield Points - ⚡ Biggest Takeaways
- Live vaccines are generally contraindicated in immunocompromised hosts.
- Exceptions include MMR and VZV, which can be given to asymptomatic HIV-infected children with adequate CD4 counts.
- Inactivated vaccines are safe but may elicit a suboptimal immune response.
- Household contacts should receive routine vaccines for cocooning, but must avoid the oral polio vaccine (OPV).
- Administer live vaccines ≥4 weeks before immunosuppression; inactivated vaccines ≥2 weeks before.
- Annual influenza and pneumococcal vaccines are critical in this group.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app